Analysts at Benchmark Co. initiated coverage on shares of Heska Corp. (NASDAQ:HSKA) in a research report issued to clients and investors on Tuesday, The Fly reports. The firm set a “buy” rating on the stock.
Several other analysts have also commented on the stock. Sidoti lowered shares of Heska Corp. from a “buy” rating to a “neutral” rating and set a $71.00 price target on the stock. in a research report on Monday. B. Riley reaffirmed a “neutral” rating and set a $55.50 price target on shares of Heska Corp. in a research report on Monday, November 7th. Finally, Zacks Investment Research raised shares of Heska Corp. from a “hold” rating to a “buy” rating and set a $63.00 price target on the stock in a research report on Wednesday, November 2nd. Three equities research analysts have rated the stock with a hold rating and four have given a buy rating to the stock. Heska Corp. currently has an average rating of “Buy” and an average target price of $63.17.
Shares of Heska Corp. (NASDAQ:HSKA) opened at 65.60 on Tuesday. The stock has a market cap of $452.51 million, a price-to-earnings ratio of 52.52 and a beta of 0.74. Heska Corp. has a 12-month low of $26.25 and a 12-month high of $69.80. The firm’s 50-day moving average price is $58.16 and its 200-day moving average price is $48.46.
Heska Corp. (NASDAQ:HSKA) last released its quarterly earnings results on Tuesday, November 1st. The company reported $0.45 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.25 by $0.20. The firm had revenue of $33.40 million for the quarter, compared to analyst estimates of $31.36 million. Heska Corp. had a net margin of 7.55% and a return on equity of 10.46%. The business’s revenue was up 19.3% on a year-over-year basis. On average, analysts forecast that Heska Corp. will post $1.32 EPS for the current fiscal year.
In related news, EVP Rod Lippincott sold 5,000 shares of Heska Corp. stock in a transaction that occurred on Tuesday, November 22nd. The shares were sold at an average price of $64.85, for a total value of $324,250.00. Following the completion of the sale, the executive vice president now owns 10,192 shares in the company, valued at approximately $660,951.20. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 15.30% of the stock is currently owned by corporate insiders.
Hedge funds have recently bought and sold shares of the stock. Ameriprise Financial Inc. bought a new stake in Heska Corp. during the second quarter valued at $1,301,000. Cadence Capital Management LLC bought a new stake in Heska Corp. during the second quarter valued at $801,000. California Public Employees Retirement System bought a new stake in Heska Corp. during the second quarter valued at $256,000. Emerald Acquisition Ltd. bought a new stake in Heska Corp. during the second quarter valued at $2,540,000. Finally, California State Teachers Retirement System increased its position in Heska Corp. by 6.1% in the second quarter. California State Teachers Retirement System now owns 12,790 shares of the company’s stock valued at $475,000 after buying an additional 735 shares during the period. Hedge funds and other institutional investors own 72.70% of the company’s stock.
About Heska Corp.
Heska Corporation develops, manufactures, markets, sells and supports veterinary products. The Company focuses on the canine and feline companion animal health markets. Its segments include Core Companion Animal Health segment, which includes, primarily for canine and feline use, blood testing instruments and supplies, digital imaging products, software and services, and single use products and services, such as heartworm diagnostic tests, heartworm preventive products, allergy immunotherapy products and allergy testing, and Other Vaccines, Pharmaceuticals and Products segment, which includes private label vaccine and pharmaceutical production, primarily for cattle but also for other animals, including small mammals.